Pages that link to "Q39880179"

The following pages link to Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation. (Q39880179):

Displaying 43 items.

• Ceramide synthases at the centre of sphingolipid metabolism and biology (Q24609859) (← links)
• STAT3 and sphingosine-1-phosphate in inflammation-associated colorectal cancer (Q26998940) (← links)
• Sphingosine kinase activity is not required for tumor cell viability (Q30452205) (← links)
• Silencing Fas-associated phosphatase 1 expression enhances efficiency of chemotherapy for colon carcinoma with oxaliplatin (Q33564927) (← links)
• The expression of sphingosine kinase-1 in head and neck carcinoma (Q33626361) (← links)
• Sphingosine kinase 1 in cancer (Q33853998) (← links)
• Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells. (Q33897852) (← links)
• Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines. (Q33914993) (← links)
• Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells (Q33916859) (← links)
• SphK1 confers resistance to apoptosis in gastric cancer cells by downregulating Bim via stimulating Akt/FoxO3a signaling (Q34105169) (← links)
• Apoptotic Sphingolipid Ceramide in Cancer Therapy (Q34736760) (← links)
• Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde (Q35264010) (← links)
• An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma (Q35268434) (← links)
• Resveratrol induces apoptosis of leukemia cell line K562 by modulation of sphingosine kinase-1 pathway (Q35653470) (← links)
• Targeting sphingosine kinase-1 to inhibit melanoma. (Q35789935) (← links)
• Sphingosine kinase 1 as an anticancer therapeutic target (Q35794452) (← links)
• Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer (Q35817821) (← links)
• Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer Cells (Q35845319) (← links)
• Liver acid sphingomyelinase inhibits growth of metastatic colon cancer (Q36580354) (← links)
• Usage of sphingosine kinase isoforms in mast cells is species and/or cell type determined (Q36625179) (← links)
• Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production (Q36744130) (← links)
• Alkaline ceramidase 2 and its bioactive product sphingosine are novel regulators of the DNA damage response (Q37109782) (← links)
• Sphingosine kinase 1 promotes malignant progression in colon cancer and independently predicts survival of patients with colon cancer by competing risk approach in South asian population (Q37614489) (← links)
• Sphingolipids in colon cancer (Q37655806) (← links)
• An oncogenic role for sphingosine kinase 2. (Q37662151) (← links)
• p53 and regulation of bioactive sphingolipids (Q37805092) (← links)
• Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases (Q37880161) (← links)
• Sphingolipid Metabolism and Analysis in Metabolic Disease (Q37930541) (← links)
• Oncogenic properties of sphingosine kinases in haematological malignancies. (Q38092176) (← links)
• Sphingosine kinase 1/S1P pathway involvement in the GDNF‐induced GAP43 transcription (Q38333309) (← links)
• Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies. (Q38909416) (← links)
• LoVo colon cancer cells resistant to oxaliplatin overexpress c-MET and VEGFR-1 and respond to VEGF with dephosphorylation of c-MET. (Q38913406) (← links)
• Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer (Q38937332) (← links)
• Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways (Q39333889) (← links)
• Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer (Q41025296) (← links)
• Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer. (Q45071199) (← links)
• Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice (Q50021960) (← links)
• Increased SPHK2 Transcription of Human Colon Cancer Cells in Serum-Depleted Culture: The Involvement of CREB Transcription Factor (Q51496711) (← links)
• IFN- Reduces Epidermal Barrier Function by Affecting Fatty Acid Composition of Ceramide in a Mouse Atopic Dermatitis Model (Q64242148) (← links)
• Interferon-γ decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis (Q85641221) (← links)
• FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression (Q90119719) (← links)
• Silencing of microRNA-708 promotes cell growth and epithelial-to-mesenchymal transition by activating the SPHK2/AKT/β-catenin pathway in glioma (Q92572430) (← links)
• A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancer (Q92876679) (← links)